27 results
8-K
EX-99.1
CNTA
Centessa Pharmaceuticals plc
10 Jun 24
Departure of Directors or Certain Officers
7:13am
for this pivotal time, we’ve added key new talent to lead our finance organization and have enhanced our strategic focus on business development,” said Saurabh
DEFA14A
CNTA
Centessa Pharmaceuticals plc
20 May 24
Additional proxy soliciting materials
8:48pm
attracting key talent, it was critical for the Company to be able to retain, appropriately incentivize and develop high caliber talent. In order to enable … -Executive Directors receive equity incentives designed to reward long-term value creation for our shareholders.
The Global Marketplace for Talent
PRE 14A
td91xm0lvzpq80dhi
26 Apr 24
Preliminary proxy
4:36pm
DEFA14A
3h300jaf3hl78sg1x
23 May 23
Additional proxy soliciting materials
4:08pm
DEFA14A
5sv4hsv p3
9 Jun 22
Additional proxy soliciting materials
9:06am
DEF 14A
okw qcucawp
23 May 22
Definitive proxy
8:00am
8-K
EX-99.2
nv9b79
30 Mar 22
Centessa Pharmaceuticals Reports Fourth Quarter and 2021 Financial Results and Provides Business Update
4:06pm
10-K
gzs3l nab
30 Mar 22
Annual report
12:00am